Hemodynamic and hormonal effects of a parenteral therapy with the ACE inhibitor quinaprilat in patients with advanced heart failure;Hamodynamische und humorale Auswirkungen einer parenteralen Therapie mit dem intravenos verabreichbaren ACE-Hemmer Quinaprilat bei Patienten mit fortgeschrittener Herzinsuffizienz

Zeitschrift fur Kardiologie

Volumn 85, Issue 11, 1996, Pages 828-838

  Mitrovic, V ^a   Mudra, H ^b   Bonzel, T ^c   Schmidt, W ^d   Schlepper, M ^a  

^a KERCKHOFF HEART CENTER   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c KLINIKUM FULDA   (Germany)

^d KLINIKUM KASSEL   (Germany)

Author keywords

heart failure; hemodynamics; neurohumoral system; quinaprilat

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NEUROHORMONE; PLACEBO; QUINAPRILAT; ALDOSTERONE; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE; HORMONE; ISOQUINOLINE DERIVATIVE; RENIN; TETRAHYDROISOQUINOLINE DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; EXTRASYSTOLE; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; RANDOMIZED CONTROLLED TRIAL; BLOOD; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG EFFECT; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGED; ALDOSTERONE; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATRIAL NATRIURETIC FACTOR; CATECHOLAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HORMONES; HUMANS; INFUSIONS, INTRAVENOUS; ISOQUINOLINES; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; RENIN; TETRAHYDROISOQUINOLINES;

EID: 0030277734     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ahmad S, Giles TD, Roffidal LE, Haney Y, Given MB, Sander GE (1990) Intravenous captopril in congestive heart failure. J Clin Pharmacol 30:609-614
2. Clealand JGF, Dargie HJ, Ball SG, et al (1985) Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J 54:305-312
3. Cody RJ, Covit AB, Schaer GL (1983) Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment of chronic congestive heart failure. J Amer Coll Cardiol 1:1154-1159
4. Cody RJ (1985) Clinical and hemodynamic experience with enalapril in congestive heart failure. Amer J Cardiol 55:36A-40A
5. Cohn JN, Johnson G, Ziesche S, et al (1991) A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Eng J Med 325:303-310
6. Cohn JN, Levine TB, Olivari MT, et al (1984) Plasma norepinephrine as a guide to diagnosis in patients with chronic heart failure. N Engl J Med 311:819-822
7. Cornyn JW, Massie BM, Unverferth DV, Leier CV (1986) Hemodynamic changes after meals and placebo treatment in chronic congestive heart failure. Amer J Cardiol 57:238-241
8. De Marco T, Daly PA, Liu M, Kayser S, Parmely WW, Chatterjee K (1987) Enalaprilat, a new parenteral angiotensin-converting enzyme inhibitor: rapid changes in systemic and coronary hemodynamics and humoral profile in chronic heart failure. J Am Coll Cardiol 9:1131-1138
9. Flapan AD, Shaw TRD, Edwards CRW, Davies E, Williams BC (1992) Contrasting patterns of arterial and venous dilatation after intravenous captopril in patients with chronic cardiac failure and their relationship to plasma angiotensin II concentrations. Am Heart J 124:1270-1276
10. Hornung RS, Hillis WS (1987) The acute haemodynamic effects of intravenous enalaprilic acid (MK422) in patients with left ventricular dysfunction. Br J Clin Pharmacol 23:29-33
11. Kramer BL, Massie BM, Topic N (1983) Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study. Circulation 67:807-816
12. Kringe K-P, Greh H, Bayha G, Kranich S, Mitrovic V (1986) HPLC-Routineanalytik von freiem Noradrenalin und Adrenalin. LHBO 22:7-12
13. Kubo SH, Cody RJ, Laragh JH, et al (1985) Immediate converting enzyme inhibition with intravenous enalapril in chronic congestive heart failure. Am J Cardiol 55:122-126
14. Langes K, Siebels J, Kuck KH (1993) Efficacy and safety of intravenous captopril in congestive heart failure. Cur Ther Res 53:167-176
15. Levine TB, Franciosa JA, Cohn JN (1980) Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure. Circulation 62:35-41
16. Levine TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN (1982) Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 49:1659-1666
17. Mitrovic V, Thormann J, Kornecki P, Volz M, Neuss H, Schlepper M (1989) The vasopressor system in patients with heart failure due to idiopathic dilated cardiomyopathy - Influence of the clinical stage of disease and of chronic drug treatment. Cardiov Drugs and Therapy 3:771-778
18. Packer M, Medina N, Yushak M (1982) Contrasting hemodynamic responses in severe heart failure: Comparison of captopril and other vasodilator drugs. Am Heart J 104:1215-23
19. Packer M, Medina N, Yushak M (1985) Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure. Circulation 71:761-766
20. Rademaker M, Shaw TRD, Williams BC, et al (1986) Intravenous captopril treatment in patients with severe cardiac failure. Br Heart J 55:187-190
21. Smedes F, Kraak JC, Poppe H (1982) Simple and fast solvent extraction system for selective and quantitative isolation of adrenaline, noradrenaline, and dopamine from plasma and urine. J Chromatography 231:25-39
22. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L for the CONSENSUS Trial Study Group (1990) Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS Trial). Am J Cardiol 66:40D-45D
23. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators (1993) Effect of ramipril on mortality of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342:821-828
24. The CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. N Eng J Med 316:1429-1435
25. The SOLVD Investigators (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327:685-691
26. The SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Eng J Med 214:293-302
27. Uretsky BF, Shaver JA, Liang Cs, et al (1988) Modulation of hemodynamic effects with a converting enzyme inhibitor: acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with oberservations on long-term clinical, functional, and biochemical responses. Am Heart J 116:480-488
28. Vander AJ, Geelhoed GW (1965) Inhibition of renin secretion by angiotensin II. Proc Soc Exp Biol Med 120:399-403
29. Volpini M, Gargano M, Cuccia C, et al (1989) Effetti emodinimici della somministrazione endovenosa di captopril in pazienti affetti da scompenso cardioaco congestizio cronico. Cardiologia 34:517-523
30. Webster MWI, Fitzpatrick MA, Hamilton EJ et al (1985) Effects of enalapril on clinical status, biochemistry, exercise performance and haemodynamics in heart failure. Drugs 30:74-81